eGenesis
Share
Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from eGenesis, Biotechnology company, Cambridge, MA.
eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.
08/23/2022
Organ transplant is the most effective solution to organ failure – but supply remains an issue. Our CEO, Mike Curtis, Ph.D., explained to Genetic Engineering & Biotechnology News how eGenesis has generated organs that have achieved long-term transplant survival in preclinical studies.
bit.ly/3SyFoyx
06/16/2022
Happy Month from all of us at eGenesis! We are proud to support a diverse and inclusive biotech industry.
06/07/2022
Our CEO, Mike Curtis, Ph.D., will be speaking on the upcoming Financial Times panel on June 9th at 11am EDT to highlight xenotransplantation as a new frontier of healthcare innovation.
To register: https://bit.ly/3mb4qoa
04/27/2022
Happy to all our company’s hardworking individuals who make our goals and developments that much more achievable. Our administrative team’s dedication to our company is essential to our goal of solving the organ shortage crisis.
04/19/2022
We are excited to announce the promotion of Michael Curtis, Ph.D. to Chief Executive Officer of eGenesis. We look forward to Dr. Curtis’ leadership as we continue to advance our portfolio toward clinical development. Dr. Curtis succeeds Paul Sekhri, who remains on the Board of Directors.
See: https://bit.ly/3Md3Oth
We are honored to sponsor the 2022 National Kidney Foundation Workshop in Washington DC. This event has brought together leaders in the field of to discuss the latest innovation in the development of xenografts for the treatment of patients with organ failure and the path ahead in advancing products to the clinic.
is a time to raise awareness of the critical wellness issues affecting our communities. Right now, more than 20 people in the US die every day waiting for a transplant. That is why we are working to put an end to the transplant shortage for a .
04/04/2022
We’re excited to welcome Eliezer Katz, M.D., FACS, our new Chief Medical Officer who has nearly 20 years of experience as a surgeon and has become a leader in clinical development of therapeutics in transplant in the pharmaceutical industry.
See: https://bit.ly/3u4YZfi
Today we recognize all the hard-working doctors, especially those physicians on our Board of Directors and Advisory Boards, who are helping us advance our human compatible organs and cells towards patients in need of a transplant.
Tomorrow, our President of Research and Development, Mike Curtis, Ph.D., is participating in a Xenotransplantation Innovation Day hosted by CareDx, Inc. He will cover the “Development of Human Compatible (HuCo) Organs and Cells with the EGEN Platform.”
To view, register here: https://bit.ly/3tYs7DO
We are excited to announce our research collaboration with the University of Miami Leonard M. Miller School of Medicine to evaluate human compatible islet cells in a clinically relevant diabetes model. This research is a prerequisite to advancing to human trials in the future if successful. The research will take place in the laboratory of Norma Sue Kenyon, Ph.D., at the Diabetes Research Institute, Miller School of Medicine.
See: https://bit.ly/360HMdp
01/31/2022
Michael Curtis, our President of R&D, explains to Science News why eGenesis, Inc. is focused first on human-compatible kidney transplant. 83 percent of the transplant waiting list are people who need kidneys.
Read here: https://bit.ly/3GjhorA
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
Cambridge, MA
02139